Shouval R, Waters NR, Gomes ALC, Zuanelli Brambilla C, Fei T, Devlin SM, Nguyen CL, Markey KA, Dai A, Slingerland JB, Clurman AG, Fontana E, Amoretti LA, Wright RJ, Hohl TM, Taur Y, Sung AD, Weber D, Hashimoto D, Teshima T, Chao NJ, Holler E, Scordo M, Giralt SA, Perales MA, Peled JU, van den Brink MRM.Conditioning Regimens are Associated with Distinct Patterns of Microbiota Injury in Allogeneic Hematopoietic Cell Transplantation.Clin Cancer Res. 2023 Jan 4;29(1):165-173. doi: 10.1158/1078-0432.CCR-22-1254.PMID: 36322005
Tamai M, Fujisawa S, Nguyen TTT, Komatsu C, Kagami K, Kamimoto K, Omachi K, Kasai S, Harama D, Watanabe A, Akahane K, Goi K, Naka K, Kaname T, Teshima T, Inukai T.Creation of Philadelphia chromosome by CRISPR/Cas9-mediated double cleavages on BCR and ABL1 genes as a model for initial event in leukemogenesis. Cancer Gene Ther. 2023 Jan;30(1):38-50. doi: 10.1038/s41417-022-00522-w. Epub 2022 Aug 23. PMID: 35999358
Yoshida S, Ara T, Okada K, Mori Y, Tsukamoto S, Miyashita N, Kasahara K, Ebata K, Iwasaki J, Takahashi S, Shigematsu A, Minauchi K, Kobayashi N, Ogasawara M, Imamura M, Teshima T, Ota S.The preceding hyponatremia is a useful hallmark for the diagnosis of HHV-6 encephalitis after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2023 Jan;58(1):97-99. doi: 10.1038/s41409-022-01843-y. Epub 2022 Oct 15. PMID: 36243759
Dertschnig S, Gergely P, Finke J, Schanz U, Holler E, Holtick U, Socié G, Medinger M, Passweg J, Teshima T, Stylianou C, Oehen S, Heim D, Bucher C. Mocravimod, a selective S1PR modulator in allogeneic hematopoietic stem cell transplantation for malignancy. Transplant Cell Ther. 2023 Jan;29(1):41.e1-41.e9. doi: 10.1016/j.jtct.2022.10.029. Epub 2022 Nov 4.PMID: 36343893
Miklos DB, Abu Zaid M, Cooney JP, Albring JC, Flowers M, Skarbnik AP, Yakoub-Agha I, Ko BS, Bruno B, Waller EK, Yared J, Sohn SK, Bulabois CE, Teshima T, Jacobsohn D, Greinix H, Mokatrin A, Lee Y, Wahlstrom JT, Styles L, Socie G. Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study. J Clin Oncol. 2023 Apr 1;41(10):1876-1887. doi: 10.1200/JCO.22.00509. Epub 2023 Jan 6. PMID: 36608310
Konuma T, Kanda J, Uchida N, Nishijima A, Tanaka M, Ozawa Y, Sawa M, Onizuka M, Ota S, Maruyama Y, Kanda Y, Kawakita T, Ara T, Eto T, Nakamae H, Kimura T, Fukuda T, Atsuta Y; Donor/Source Working Group of theJapanese Society for Transplantation and Cellular Therapy.Intensified conditioning regimens improved disease-free survival and engraftment after unrelated single-unit cord blood transplantation but not after matched sibling or matched unrelated donor allogeneic hematopoietic cell transplantation.Hematol Oncol. 2023 Feb;41(1):147-158. doi: 10.1002/hon.3094. Epub 2022 Oct 31.PMID: 36268564
Sudo H, Miyakoshi T, Watanabe Y, Ito YM, Kahata K, Tha KK, Yokota N, Kato H, Terada T, Iwasaki N, Arato T, Sato N, Isoe T.Protocol for treating lumbar spinal canal stenosis with a combination of ultrapurified, allogenic bone marrow-derived mesenchymal stem cells and in situ-forming gel: a multicentre, prospective, double-blind randomised controlled trial.BMJ Open. 2023 Feb 2;13(2):e065476. doi: 10.1136/bmjopen-2022-065476.
Fukuhara N, Kato K, Goto H, Takeshi T, Kawaguchi M, Tokushige K, Akashi K, Teshima T, Harigae H, Schuster SJ, Thieblemont C, Dreyling M, Fowler N.Efficacy and safety of tisagenlecleucel in adult Japanese patients with relapsed or refractory follicular lymphoma: results from the phase 2 ELARA trial. Int J Hematol. 2023 Feb;117(2):251-259. doi: 10.1007/s12185-022-03481-y. Epub 2022 Nov 21. PMID: 36404384
Inoue T, Shinnakasu R, Kawai C, Yamamoto H, Sakakibara S, Ono C, Itoh Y, Terooatea T, Yamashita K, Okamoto T, Hashii N, Ishii-Watabe A, Butler NS, Matsuura Y, Matsumoto H, Otsuka S, Hiraoka K, Teshima T, Murakami M, Kurosaki T. Antibody feedback contributes to facilitating the development of Omicron-reactive memory B cells in SARS-CoV-2 mRNA vaccinees. J Exp Med. 2023 Feb 6;220(2):e20221786. doi: 10.1084/jem.20221786. Epub 2022 Dec 13. PMID: 36512034
Nakano K, Sugita J, Seimiya M, Yasuda K, Watanabe C, Goto H, Teshima T.IgG4-IgE complex interferes with measurement of IgE concentration. Clin Biochem. 2023 Feb;112:11-16. doi: 10.1016/j.clinbiochem.2022.12.006. Epub 2022 Dec 9. PMID: 36509149
Yanagisawa R, Hirakawa T, Doki N, Ikegame K, Matsuoka KI, Fukuda T, Nakamae H, Ota S, Hiramoto N, Ishikawa J, Ara T, Tanaka M, Koga Y, Kawakita T, Maruyama Y, Kanda Y, Hino M, Atsuta Y, Yabe H, Tsukada N.Severe short-term adverse events in related bone marrow or peripheral blood stem cell donors.Int J Hematol. 2023 Mar;117(3):421-427. doi: 10.1007/s12185-022-03489-4. Epub 2022 Nov 20.PMID: 36403180
Kamijo K, Shimomura Y, Shinohara A, Mizuno S, Kanaya M, Usui Y, Kim SW, Ara T, Mizuno I, Kuriyama T, Nakazawa H, Matsuoka KI, Kusumoto S, Maseki N, Yamaguchi M, Ashida T, Onizuka M, Fukuda T, Atsuta Y, Kondo E.Fludarabine plus reduced-intensity busulfan versus fludarabine plus myeloablative busulfan in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic cell transplantation.Ann Hematol. 2023 Mar;102(3):651-661. doi: 10.1007/s00277-023-05084-x. Epub 2023 Jan 12.PMID: 36631705
Kimura SI, Akahoshi Y, Shiratori S, Okinaka K, Harada K, Uchida N, Doki N, Ikegame K, Nakamae H, Tanaka M, Takada S, Kawakita T, Matsuoka KI, Ara T, Ota S, Sawa M, Onizuka M, Fukuda T, Atsuta Y, Kanda Y, Nakasone H.Association Between Candidemia and Noninfectious Interstitial Pneumonia After Allogeneic Hematopoietic Cell Transplantation: JSTCT Transplant Complications Working Group.Open Forum Infect Dis. 2023 Mar 27;10(4):ofad163. doi: 10.1093/ofid/ofad163. eCollection 2023 Apr.PMID: 37089776
Hiroki Matsumura, Larina Tzu-Wei Shen, Akihiro Isozaki, Hideharu Mikami, Dan Yuan, Taichi Miura, Yuto Kondo, Tomoko Mori, Yoshika Kusumoto, Masako Nishikawa, Atsushi Yasumoto, Aya Ueda, Hiroko Bando, Hisato Hara, Yuhong Liu, Yunjie Deng, Masahiro Sonoshita, Yutaka Yatomi, Keisuke Goda, Satoshi MatsusakaVirtual-freezing fluorescence imaging flow cytometry with 5-aminolevulinic acid stimulation and antibody labeling for detecting all forms of circulating tumor cells.Lab Chip. 2023 Mar 14;23(6):1561-1575. doi: 10.1039/d2lc00856d.PMID: 36648503
Kato K, Fujii N, Makita S, Goto H, Kanda J, Shimada K, Akashi K, Izutsu K, Teshima T, Fukuda N, Sumitani T, Nakamura S, Sumi H, Shimizu S, Kakurai Y, Yoshikawa K, Tobinai K, Usui N, Hatake K.A phase 2 study of axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma in Japan: 1-year follow-up and biomarker analysis. Int J Hematol. 2023 Mar;117(3):409-420. doi: 10.1007/s12185-022-03494-7. Epub 2022 Nov 18. PMID: 36399286
Mori A, Onozawa M, Kobayashi M, Tsukamoto S, Senjo H, Ishio T, Yokoyama E, Izumiyama K, Saito M, Muraki H, Morioka M, Teshima T, Kondo T. Humoral response to mRNA-based COVID-19 vaccine in patients with immune thrombocytopenia. Br J Haematol. 2023 Mar;200(6):717-721. doi: 10.1111/bjh.18578. Epub 2022 Nov 28. PMID: 36442510
Nakamura S, Nakamura K, Yokoi Y, Shimizu Y, Ohira S, Hagiwara M, Song Z, Gan L, Aizawa T, Hashimoto D, Teshima T, Ouellette AJ, Ayabe T. Decreased Paneth cell α-defensins promote fibrosis in a choline-deficient L-amino acid-defined high-fat diet-induced mouse model of nonalcoholic steatohepatitis via disrupting intestinal microbiota. Sci Rep. 2023 Mar 9;13(1):3953. doi: 10.1038/s41598-023-30997-y. PMID: 36894646
Nakamura S, Nakamura K, Yokoi Y, Shimizu Y, Ohira S, Hagiwara M, Song Z, Gan L, Aizawa T, Hashimoto D, Teshima T, Ouellette AJ, Ayabe T. Decreased Paneth cell α-defensins promote fibrosis in a choline-deficient L-amino acid-defined high-fat diet-induced mouse model of nonalcoholic steatohepatitis via disrupting intestinal microbiota. Sci Rep. 2023 Mar 9;13(1):3953. doi: 10.1038/s41598-023-30997-y. PMID: 36894646
Konuma T, Itonaga H, Ishiyama K, Hamamura A, Uchida N, Ozawa Y, Katayama Y, Sakurai M, Ueda Y, Matsuoka KI, Kawakita T, Eto T, Ara T, Kanda J, Onizuka M, Fukuda T, Atsuta Y.Progress in survival following three decades of allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: A real-world registry study in Japan.Am J Hematol. 2023 Apr;98(4):E68-E71. doi: 10.1002/ajh.26839. Epub 2023 Jan 24.PMID: 36633538
Perl AE, Larson RA, Podoltsev NA, Strickland S, Wang ES, Atallah E, Schiller GJ, Martinelli G, Neubauer A, Sierra J, Montesinos P, Recher C, Yoon SS, Maeda Y, Hosono N, Onozawa M, Kato T, Kim HJ, Hasabou N, Nuthethi R, Tiu R, Levis MJ.Outcomes in Patients with FLT3-Mutated Relapsed/ Refractory Acute Myelogenous Leukemia Who Underwent Transplantation in the Phase 3 ADMIRAL Trial of Gilteritinib versus Salvage Chemotherapy.Transplant Cell Ther. 2023 Apr;29(4):265.e1-265.e10. doi: 10.1016/j.jtct.2022.12.006. Epub 2022 Dec 13.
Okinaka K, Akeda Y, Inamoto Y, Fuji S, Ito A, Tanaka T, Kurosawa S, Kim SW, Tanosaki R, Yamashita T, Ohwada C, Kurata K, Mori T, Onozawa M, Takano K, Yokoyama H, Koh K, Nagafuji K, Nakayama K, Sakura T, Takahashi T, Oishi K, Fukuda T.Immunogenicity of three versus four doses of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in allogeneic haematopoietic stem cell transplantation recipients: a multicentre, randomized controlled trial.Clin Microbiol Infect. 2023 Apr;29(4):482-489. doi: 10.1016/j.cmi.2022.12.007. Epub 2022 Dec 8.
Yuqin Song, Hervé Tilly, Shinya Rai, Huilai Zhang, Jie Jin, Hideki Goto, Yasuhito Terui, Ho-Jin Shin, Won Seog Kim, Junning Cao, Jifeng Feng, Hyeon Seok Eom, Tae Min Kim, Xavier Cheng-Hong Tsai, Jyh-Pyng Gau, Hideo Koh, Liling Zhang, Yongping Song, Yu Yang, Wei Li, He Huang, Kiyoshi Ando, Jeff P Sharman, Laurie H Sehn, Lilian Bu, Xin Wang, Yanwen Jiang, Jamie Hirata, Calvin Lee, Jun Zhu, Koji Izutsu.Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trialBlood. 2023 Apr 20;141(16):1971-1981.
Shimomura Y, Kitamura T, Nishikubo M, Sobue T, Uchida N, Doki N, Tanaka M, Ito A, Ishikawa J, Ara T, Ota S, Onizuka M, Sawa M, Ozawa Y, Maruyama Y, Ikegame K, Kanda Y, Ichinohe T, Fukuda T, Okamoto S, Teshima T, Atsuta Y.Effect of the COVID-19 pandemic on allogeneic stem cell transplantation in Japan. Int J Hematol. 2023 Apr;117(4):590-597. doi: 10.1007/s12185-022-03508-4. Epub 2022 Dec 14. PMID: 36515796
Yoshida S, Onozawa M, Miyashita N, Kimura H, Takahashi S, Yokoyama S, Matsukawa T, Hirabayashi S, Mori A, Hidaka D, Minauchi K, Shigematsu A, Hashiguchi J, Igarashi T, Kakinoki Y, Tsutsumi Y, Ibata M, Kobayashi H, Haseyama Y, Fujimoto K, Ishihara T, Sakai H, Ota S, Kondo T, Teshima T.Clinical features of complex karyotype in newly diagnosed acute myeloid leukemia. Int J Hematol. 2023 Apr;117(4):544-552. doi: 10.1007/s12185-022-03522-6. Epub 2022 Dec 26. PMID: 36572814
Itonaga H, Miyazaki Y, Aoki K, Shingai N, Ozawa Y, Fukuda T, Kataoka K, Kawakita T, Ueda Y, Ara T, Tanaka M, Katayama Y, Sawa M, Eto T, Kanda J, Atsuta Y, Ishiyama K.Allogeneic transplantation of bone marrow versus peripheral blood stem cells from HLA-identical relatives in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukemia: a propensity score analysis of a nationwide database.Ann Hematol. 2023 May;102(5):1215-1227. doi: 10.1007/s00277-023-05167-9. Epub 2023 Mar 15.PMID: 36918415
Jo T, Arai Y, Kanda J, Kondo T, Ikegame K, Uchida N, Doki N, Fukuda T, Ozawa Y, Tanaka M, Ara T, Kuriyama T, Katayama Y, Kawakita T, Kanda Y, Onizuka M, Ichinohe T, Atsuta Y, Terakura S.A convolutional neural network-based model that predicts acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.Commun Med (Lond). 2023 May 16;3(1):67. doi: 10.1038/s43856-023-00299-5.PMID: 37193882
Nakano K, Sugawa S, Seimiya M, Murakami S, Yasuda K, Watanabe C, Goto H, Teshima T. Frequencies of Anti-Troponin I vs Anti-Troponin T Autoantibodies and Degrees of Interference on Troponin Assays. Lab Med. 2023 May 2;54(3):317-323. doi: 10.1093/labmed/lmac120. PMID: 36322014
Grupp SA, Corbacioglu S, Kang HJ, Teshima T, Khaw SL, Locatelli F, Maertens J, Stelljes M, Stepensky P, Lopez P, Amber V, Pagliuca A, Richardson PG, Mohty M. Defibrotide plus best standard of care compared with best standard of care alone for the prevention of sinusoidal obstruction syndrome (HARMONY): a randomised, multicentre, phase 3 trial. Lancet Haematol. 2023 May;10(5):e333-e345. doi: 10.1016/S2352-3026(23)00011-X. Epub 2023 Mar 28. PMID: 37001534
Otani M, Shiino T, Hachiya A, Gatanaga H, Watanabe D, Minami R, Nishizawa M, Teshima T, Yoshida S, Ito T, Hayashida T, Koga M, Nagashima M, Sadamasu K, Kondo M, Kato S, Uno S, Taniguchi T, Igari H, Samukawa S, Nakajima H, Yoshino Y, Horiba M, Moro H, Watanabe T, Imahashi M, Yokomaku Y, Mori H, Fujii T, Takada K, Nakamura A, Nakamura H, Tateyama M, Matsushita S, Yoshimura K, Sugiura W, Matano T, Kikuchi T. Japanese Drug Resistance HIV-1 Surveillance Network: Association of demographics, HCV co-infection, HIV-1 subtypes and genetic clustering with late HIV diagnosis: a retrospective analysis from the Japanese Drug Resistance HIV-1 Surveillance Network. J Int AIDS Soc. 2023 May;26(5):e26086. doi: 10.1002/jia2.26086. PMID: 37221951
Tsutsumi Y, Ito S, Shiratori S, Teshima T.Hepatitis C Virus (HCV)-Ribonucleic Acid (RNA) As a Biomarker for Lymphoid Malignancy with HCV Infection. Cancers (Basel). 2023 May 21;15(10):2852. doi: 10.3390/cancers15102852. PMID: 37345190
Konuma T, Matsuda K, Shimomura Y, Tanoue S, Sugita J, Inamoto Y, Hirayama M, Ara T, Nakamae H, Ota S, Maruyama Y, Eto T, Uchida N, Tanaka M, Ishiwata K, Koi S, Takahashi S, Ozawa Y, Onizuka M, Kanda Y, Kimura T, Ichinohe T, Atsuta Y, Kanda J, Yanada M.Effect of Graft-versus-Host Disease on Post-Transplantation Outcomes following Single Cord Blood Transplantation Compared with Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Adult Acute Myeloid Leukemia.Transplant Cell Ther. 2023 Jun;29(6):365.e1-365.e11. doi: 10.1016/j.jtct.2023.03.001. Epub 2023 Mar 6.PMID: 36889507
Akahoshi Y, Nakasone H, Takenaka K, Yamasaki S, Nakamura M, Doki N, Tanaka M, Ozawa Y, Uchida N, Ara T, Nakamae H, Ota S, Onizuka M, Yano S, Tanaka J, Fukuda T, Kanda Y, Atsuta Y, Kako S, Yanada M, Arai Y.CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia.Blood Adv. 2023 Jun 27;7(12):2699-2708. doi: 10.1182/bloodadvances.2022009376.PMID: 36661335
Yokoyama S, Onozawa M, Yoshida S, Miyashita N, Kimura H, Takahashi S, Matsukawa T, Goto H, Fujisawa S, Miki K, Hidaka D, Hashiguchi J, Wakasa K, Ibata M, Takeda Y, Shigematsu A, Fujimoto K, Tsutsumi Y, Mori A, Ishihara T, Kakinoki Y, Kondo T, Hashimoto D, Teshima T.Subclinical minute FLT3-ITD clone can be detected in clinically FLT3-ITD-negative acute myeloid leukaemia at diagnosis.Br J Haematol. 2023 Jun;201(6):1144-1152. doi: 10.1111/bjh.18800. Epub 2023 Apr 17.PMID: 37067758
Goto H, Kitawaki T, Fujii N, Kato K, Onishi Y, Fukuhara N, Yamauchi T, Toratani K, Kobayashi H, Yoshida S, Shimo M, Onodera K, Senjo H, Onozawa M, Hirata K, Yokota I, Teshima T. Safety and efficacy of tisagenlecleucel in patients with relapsed or refractory B-cell lymphoma: the first real-world evidence in Japan. Int J Clin Oncol. 2023 Jun;28(6):816-826. doi: 10.1007/s10147-023-02334-w. Epub 2023 Apr 18. PMID: 37071252
Jo T, Arai Y, Oshima S, Kondo T, Harada K, Uchida N, Doki N, Fukuda T, Tanaka M, Ozawa Y, Kuriyama T, Ikegame K, Katayama Y, Ota S, Ara T, Kawakita T, Onizuka M, Ichinohe T, Atsuta Y, Yanada M; Japanese Society for Transplantation and Cellular Therapy (JSTCT).Prognostic impact of complex and/or monosomal karyotypes in post-transplant poor cytogenetic acute myeloid leukaemia: A quantitative approach.Br J Haematol. 2023 Jul;202(2):356-368. doi: 10.1111/bjh.18855. Epub 2023 May 21.PMID: 37211753
Jo T, Yoshihara S, Okuyama Y, Fujii K, Henzan T, Kahata K, Yamazaki R, Takeda W, Umezawa Y, Fukushima K, Ashida T, Yamada-Fujiwara M, Hanajiri R, Yonetani N, Tada Y, Shimura Y, Nishikii H, Shiba N, Mimura N, Ando J, Sato T, Nakashima Y, Ikemoto J, Iwaki K, Fujiwara SI, Ri M, Nagamura-Inoue T, Tanosaki R, Arai Y.Risk factors for CAR-T cell manufacturing failure among DLBCL patients: A nationwide survey in Japan.Br J Haematol. 2023 Jul;202(2):256-266. doi: 10.1111/bjh.18831. Epub 2023 Apr 25.
Miyashita N, Onozawa M, Yoshida S, Kimura H, Takahashi S, Yokoyama S, Matsukawa T, Hirabayashi S, Fujisawa S, Mori A, Ota S, Kakinoki Y, Tsutsumi Y, Yamamoto S, Miyagishima T, Nagashima T, Ibata M, Wakasa K, Haseyama Y, Fujimoto K, Ishihara T, Sakai H, Kondo T, Teshima T. Prognostic impact of FLT3-ITD, NPM1 mutation and CEBPA bZIP domain mutation in cytogenetically normal acute myeloid leukemia: a Hokkaido Leukemia Net study. Int J Hematol. 2023 Jul;118(1):36-46. doi: 10.1007/s12185-023-03567-1. Epub 2023 Feb 28. PMID: 36853451
Yanagisawa R, Tamaki M, Tanoshima R, Misaki Y, Uchida N, Koi S, Tanaka T, Ozawa Y, Matsuo Y, Tanaka M, Ikegame K, Katayama Y, Matsuoka KI, Ara T, Kanda Y, Matsumoto K, Fukuda T, Atsuta Y, Kato M, Nakasone H.Risk factors for fatal cardiac complications after allogeneic hematopoietic cell transplantation: Japanese Society for Transplantation and Cellular Therapy transplant complications working group.Hematol Oncol. 2023 Aug;41(3):535-545. doi: 10.1002/hon.3101. Epub 2022 Nov 25.PMID: 36385399
Ishida H, Shimada H, Tanizawa A, Shimazu Y, Tachibana T, Doki N, Ara T, Matsuo Y, Nara M, Toubai T, Ino K, Nakamae H, Kato K, Kato K, Sato A, Hino M, Matsumoto K, Atsuta Y, Yasui M, Nagamura-Inoue T.Allogeneic stem cell transplantation for children and adolescents/young adults with de novo blastic phase chronic myeloid leukemia in the tyrosine kinase inhibitor era.Am J Hematol. 2023 Aug;98(8):E200-E203. doi: 10.1002/ajh.26959. Epub 2023 May 12.PMID: 37170859
Senjo H, Harada S, Kubota SI, Tanaka Y, Tateno T, Zhang Z, Okada S, Chen X, Kikuchi R, Miyashita N, Onozawa M, Goto H, Endo T, Hasegawa Y, Ohigashi H, Ara T, Hasegawa Y, Murakami M, Teshima T(equally contributing senior author), Hashimoto D. Calcineurin inhibitor inhibits tolerance induction by suppressing terminal exhaustion of donor T cells after allo-HCT. Blood. 2023 Aug 3;142(5):477-492. doi: 10.1182/blood.2023019875. PMID: 37216687
Mori A, Onozawa M, Kobayashi M, Tsukamoto S, Senjo H, Ishio T, Yokoyama E, Kanaya M, Izumiyama K, Saito M, Muraki H, Morioka M, Teshima T, Kondo T. Booster effect of a third mRNA-based COVID-19 vaccine dose in patients with myeloid malignancies. Cancer Med. 2023 Aug;12(16):16881-16888. doi: 10.1002/cam4.6314. Epub 2023 Jul 6. PMID: 37409608
Saburi M, Oshima K, Takano K, Inoue Y, Harada K, Uchida N, Fukuda T, Doki N, Ikegame K, Matsuo Y, Katayama Y, Ozawa Y, Matsuoka KI, Kawakita T, Mori Y, Ara T, Nakamae H, Kimura T, Kanda Y, Atsuta Y, Ogata M; Transplant Complications Working Group of the Japanese Society for Transplantation and Cellular Therapy.Risk factors and outcome of Stenotrophomonas maltophilia infection after allogeneic hematopoietic stem cell transplantation: JSTCT, Transplant Complications Working Group.Ann Hematol. 2023 Sep;102(9):2507-2516. doi: 10.1007/s00277-023-05320-4. Epub 2023 Jun 20.PMID: 37338625
Yanada M, Shimomura Y, Mizuno S, Matsuda K, Kondo T, Doki N, Tanaka M, Fukuda T, Ara T, Uchida N, Onizuka M, Sawa M, Ozawa Y, Hiramoto N, Ota S, Kanda J, Kanda Y, Ichinohe T, Okamoto S, Atsuta Y, Konuma T.External validation and extended application of the transplant conditioning intensity score in acute myeloid leukemia.Bone Marrow Transplant. 2023 Oct;58(10):1096-1103. doi: 10.1038/s41409-023-02037-w. Epub 2023 Jul 13.PMID: 37443251
Kikuchi M, Iwai T, Nishida M, Kudo Y, Omotehara S, Sato M, Sugita J, Goto H, Yokota I, Teshima T.Assessment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome using different scanning approaches for the ultrasonographic evaluation of portal vein blood flow and hepatic artery resistive index in hematopoietic stem cell transplant recipients. J Med Ultrason (2001). 2023 Oct;50(4):465-471. doi: 10.1007/s10396-023-01335-6. Epub 2023 Jul 4. PMID: 37402021
Miyajima T, Onozawa M, Yoshida S, Miyashita N, Kimura H, Takahashi S, Yokoyama S, Matsukawa T, Goto H, Sugita J, Fujisawa S, Hidaka D, Ogasawara R, Mori A, Matsuoka S, Shigematsu A, Wakasa K, Kasahara I, Saga T, Hashiguchi J, Takeda Y, Ibata M, Yutaka T, Fujimoto K, Kondo T, Teshima T. Clinical implications of NUP98::NSD1 fusion at diagnosis in adult FLT3-ITD positive AML. Eur J Haematol. 2023 Oct;111(4):620-627. doi: 10.1111/ejh.14055. Epub 2023 Jul 19. PMID: 37465857
Kagami K, Oyamada R, Watanabe T, Nakakubo S, Hayashi T, Iwasaki S, Fukumoto T, Usami T, Hayasaka K, Fujisawa S, Watanabe C, Nishida M, Teshima T, Niinuma Y, Yokota I, Takekuma Y, Sugawara M, Ishiguro N. Factors associated with household transmission of SARS-CoV-2 omicron variant to health care workers: A retrospective cohort study. Int J Nurs Pract. 2023 Oct;29(5):e13195. doi: 10.1111/ijn.13195. Epub 2023 Aug 24. PMID: 37621085
Tsutsumi Y, Ito S, Horikita F, Moriki A, Teshima T. COVID‑19 antibody production by vaccination in chemotherapy with CD20 antibody for B‑cell lymphoma. Mol Clin Oncol. 2023 Oct 18;19(6):96. doi: 10.3892/mco.2023.2692. eCollection 2023 Dec. PMID: 37920416
Mori H, Koyama D, Sato Y, Kataoka Y, Taito S, Ishio T, Teshima T, Yokota I.Prognostic Value of Hematogones in Patients With Hematopripoietic Disorders After Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis. Cureus. 2023 Oct 17;15(10):e47184. doi: 10.7759/cureus.47184. eCollection 2023 Oct. PMID: 37854480
Shiratori S, Okada K, Sugita J, Nishida M, Iwai T, Ota S, Hashimoto D, Teshima T. HokUS-10 scoring system predicts the treatment outcome for sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation. Sci Rep. 2023 Oct 13;13(1):17374. doi: 10.1038/s41598-023-43806-3. PMID: 37833418
Ichikawa T, Tamura T, Takahata M, Ishio T, Ibata M, Kasahara I, Minauchi K, Yamamoto S, Teshima T, Fukuhara T.Prolonged shedding of viable SARS-CoV-2 in immunocompromised patients with haematological malignancies: A prospective study. Br J Haematol. 2023 Oct 5. doi: 10.1111/bjh.19143. Online ahead of print. PMID: 37795527
Fuji S, Hakoda A, Kanda J, Fukuda T, Doki N, Katayama Y, Uchida N, Ozawa Y, Kanda Y, Tanaka M, Kataoka K, Ara T, Sawa M, Onizuka M, Onishi Y, Kimura T, Ichinohe T, Atsuta Y, Shintani A, Morishima S.Impact of HLA disparity on overall mortality risk in patients with extensive chronic GVHD: The HLA Working Group of Japanese Society for Transplantation and Cellular Therapy.Bone Marrow Transplant. 2023 Nov;58(11):1257-1259. doi: 10.1038/s41409-023-02076-3. Epub 2023 Aug 7.PMID: 37550450
Watanabe M, Kanda J, Fukuda T, Uchida N, Ikegame K, Kataoka K, Kobayashi H, Ara T, Ishikawa J, Matsuoka KI, Sugio Y, Nakazawa H, Ikeda T, Atsuta Y, Kondo E, Suzuki R; Japanese Society for Transplantation and Cellular Therapy, Adult Lymphoma Working Group.Impact of GVHD on lymphoma progression: Nationwide study from Japanese Society for Transplantation and Cellular Therapy.Br J Haematol. 2023 Nov;203(3):446-459. doi: 10.1111/bjh.19041. Epub 2023 Aug 23.PMID: 37614023
Chang YS, Gills JJ, Kawabata S, Onozawa M, Della Gatta G, Ferrando AA, Aplan PD, Dennis PA.Inhibition of the NOTCH and mTOR pathways by nelfinavir as a novel treatment for T cell acute lymphoblastic leukemiaInt J Oncol. 2023 Nov;63(5):128. doi: 10.3892/ijo.2023.5576. Epub 2023 Oct 6.
Kagami K, Kitajima M, Takahashi H, Teshima T, Ishiguro N.Association of wastewater SARS-CoV-2 load with confirmed COVID-19 cases at a university hospital in Sapporo, Japan during the period from February 2021 to February 2023. Sci Total Environ. 2023 Nov 15;899:165457. doi: 10.1016/j.scitotenv.2023.165457. Epub 2023 Jul 25. PMID: 37499823
Kimura H, Onozawa M, Yoshida S, Miyashita N, Yokoyama S, Matsukawa T, Hirabayashi S, Goto H, Endo T, Oguri S, Fujisawa S, Mori A, Kondo T, Hidaka D, Okada K, Ota S, Kakinoki Y, Tsutsumi Y, Yamamoto S, Miyagishima T, Hashiguchi J, Nagashima T, Ibata M, Wakasa K, Haseyama Y, Fujimoto K, Ishihara T, Sakai H, Teshima T. Dominant-negative type of IKZF1 deletion showed a favorable prognosis in adult B-cell acute lymphoblastic leukemia. Ann Hematol. 2023 Nov;102(11):3103-3113. doi: 10.1007/s00277-023-05405-0. Epub 2023 Aug 19. PMID: 37597110
Murakami K, Kubota SI, Tanaka K, Tanaka H, Akabane K, Suzuki R, Shinohara Y, Takei H, Hashimoto S, Tanaka Y, Hojyo S, Sakamoto O, Naono N, Takaai T, Sato K, Kojima Y, Harada T, Hattori T, Fuke S, Yokota I, Konno S, Washio T, Fukuhara T, Teshima T, Taniguchi M, Murakami M. High-precision rapid testing of omicron SARS-CoV-2 variants in clinical samples using AI-nanopore. Lab Chip. 2023 Nov 7;23(22): 4909-4918. doi: 10.1039/d3lc00572k. PMID: 37877206
Goto H, Sugita J, Hasegawa Y, Hayasaka K, Sunagoya K, Hatase R, Nishida M, Ichihashi Y, Odera M, Senjo H, Yokoyama S, Ara T, Shiratori S, Endo T, Hino M, Maeda Y, Sawa M, Sato N, Teshima T. Efficacy and Safety of Single-dose Pegfilgrastim for CD34+ Cell Mobilization in Healthy Volunteers: A Phase 2 Study. Transplantation. 2023 Nov 28. doi: 10.1097/TP.0000000000004880. Online ahead of print. PMID: 38012835
Kimura H, Onozawa M, Hashiguchi J, Hidaka D, Kanaya M, Matsukawa T, Okada H, Kondo T, Matsuno Y, Teshima T.Hereditary thrombocythemia due to splicing donor site mutation of THPO in a Japanese family. Ann Hematol. 2023 Nov 14. doi: 10.1007/s00277-023-05523-9. Online ahead of print. PMID: 37962621
Kimura H, Onozawa M, Teshima T. Genetic background of thrombocytosis in mice mimicking hereditary thrombocytosis in humans. Platelets. 2023 Dec;34(1):2276697. doi: 10.1080/09537104.2023.2276697. Epub 2023 Nov 9. PMID: 37941443
Ohbiki M, Ito Y, Inamoto Y, Miyamura K, Uchida N, Fukuda T, Fujiwara H, Nishida T, Hayashi M, Tanaka M, Kawakita T, Ikegame K, Katayama Y, Ara T, Ichinohe T, Kiyoi H, Matsuo K, Atsuta Y.Improved Long-Term Net Survival after Allogeneic Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies over Two Decades.Transplant Cell Ther. 2023 Dec;29(12):768.e1-768.e10. doi: 10.1016/j.jtct.2023.09.010. Epub 2023 Sep 21.PMID: 37739224
Hayase E, Ara T, Saito Y, Takahashi S, Yoshioka K, Ohigashi H, Ogasawara R, Yokoyama E, Yamakawa T, Ebata K, Hasegawa Y, Tomizuka K, Teshima T.R-Spondin1 protects gastric stem cells and mitigates gastric GVHD in allogeneic hematopoietic stem cell transplantation.Blood Adv. 2023 Dec 26:bloodadvances.2023011034. doi: 10.1182/bloodadvances.2023011034. Online ahead of print.PMID: 38147622
Vaswani PPM, Onozawa M, Hasegawa Y, Ohigashi H, Ara T, Matsukawa T, Yasumoto A, Shiratori S, Goto H, Nakagawa M, Kahata K, Endo T, Hashimoto D, Teshima T.Incidence and course of Epstein-Barr virus viremia after allogeneic hematopoietic stem cell transplant for adult-onset systemic chronic active Epstein-Barr virus disease.Bone Marrow Transplant. 2023 Dec;58(12):1397-1399. doi: 10.1038/s41409-023-02103-3. Epub 2023 Sep 5.PMID: 37670048
Uno S, Gatanaga H, Hayashida T, Imahashi M, Minami R, Koga M, Samukawa S, Watanabe D, Fujii T, Tateyama M, Nakamura H, Matsushita S, Yoshino Y, Endo T, Horiba M, Taniguchi T, Moro H, Igari H, Yoshida S, Teshima T, Nakajima H, Nishizawa M, Yokomaku Y, Iwatani Y, Hachiya A, Kato S, Hasegawa N, Yoshimura K, Sugiura W, Kikuchi T. Virological outcomes of various first-line ART regimens in patients harbouring HIV-1 E157Q integrase polymorphism: a multicentre retrospective study. J Antimicrob Chemother. 2023 Dec 1;78(12):2859-2868. doi: 10.1093/jac/dkad319. PMID: 37856677
Sugita J, Kuroha T, Ishikawa J, Eto T, Fukushima K, Yokota I, Akashi K, Taniguchi S, Harada M, Teshima T: Posttransplant cyclophosphamide in unrelated and related peripheral blood stem cell transplantation from HLA-matched and 1 allele mismatched donor. Bone Marrow Transplant. 2023 Dec 19. doi: 10.1038/s41409-023-02162-6. Online ahead of print. PMID: 38114645
Chiba M, Shimono J, Suto K, Ishio T, Endo T, Goto H, Hasegawa H, Maeda M, Teshima T, Yang Y, Nakagawa M. Whole genome CRISPR screening identifies molecular mechanisms of PD-L1 expression in Adult T-cell leukemia/lymphoma. Blood. 2023 Dec 24:blood.2023021423. doi: 10.1182/blood.2023021423. Online ahead of print. PMID: 38142436
Minakata D, Uchida T, Nakano A, Takase K, Tsukada N, Kosugi H, Kawata E, Nakane T, Takahashi H, Endo T, Nishiwaki S, Fujiwara H, Saito MA, Saito IT, Akashi K, Matsumura I, Mitani K. Characteristics and prognosis of patients with COVID-19 and hematological diseases in Japan: a cross-sectional study.Int J Hematol. Online ahead of print.
英文総説
Teshima T, Boelens JJ, Matsuoka KI.Novel insights into GVHD and immune reconstitution after allogeneic hematopoietic cell transplantation. Blood Cell Ther. 2023 Apr 21;6(2):42-48. doi: 10.31547/bct-2022-023. eCollection 2023 May 25. PMID: 37342354
Tsutsumi Y, Ito S, Shiratori S, Teshima T.Hepatitis C Virus (HCV)-Ribonucleic Acid (RNA) As a Biomarker for Lymphoid Malignancy with HCV Infection.Cancers (Basel). 2023 May 21;15(10):2852. doi: 10.3390/cancers15102852.PMID: 3734519
Teshima T, Hashimoto D.Separation of GVL from GVHD -location, location, location. Front Immunol. 2023 Dec 5;14:1296663. doi: 10.3389/fimmu.2023.1296663. eCollection 2023. PMID: 38116007
英文症例報告
Munekata Y, Yamamoto S, Kato S, Kitagawa Y, Enda K, Okazaki N, Tanikawa S, Tanei ZI, Ikebe Y, Osawa T, Takamiya S, Ujiie H, Onozawa M, Hirano S, Fujimura M, Tanaka S.Fatal case of subdural empyema caused by Campylobacter rectus and Slackia exigua.Autops Case Rep. 2023 May 24;13:e2023433. doi: 10.4322/acr.2023.433. eCollection 2023.
Kikuchi R, Onozawa M, Nagai J, Okada S, Hasegawa Y, Ohigashi H, Mitamura S, Maeda T, Takakuwa E, Fujieda Y, Goto H, Hashimoto D, Matsuno Y, Teshima T.Type 1 Cryoglobulinemic Vasculitis Due to Monoclonal Gammopathy of Undetermined Significance Successfully Treated by Bortezomib Plus Dexamethasone. Intern Med. 2023 Jun 14. doi: 10.2169/internalmedicine.2053-23. Online ahead of print. PMID: 37316269
Kikuchi R, Onozawa M, Nagai J, Okada S, Hasegawa Y, Ohigashi H, Mitamura S, Maeda T, Takakuwa E, Fujieda Y, Goto H, Hashimoto D, Matsuno Y, Teshima T.Type 1 Cryoglobulinemic Vasculitis Due to Monoclonal Gammopathy of Undetermined Significance Successfully Treated by Bortezomib Plus Dexamethasone. Intern Med. 2023 Jun 14. doi: 10.2169/internalmedicine.2053-23. Online ahead of print. PMID: 37316269
Komatsumoto M, Nakazawa D, Endo T, Nishio S, Kawamura T, Miyoshi-Harashima A, Takenaka S, Shiratori-Aso S, Kurotori M, Matsuoka N, Atsumi T.Successful initiation of hemodialysis for a hemophilia A patient with factor VIII inhibitor: a case report and literature review.CEN Case Rep. 2023 Jul 25. doi: 10.1007/s13730-023-00811-9. Online ahead of print.PMID: 37490239
Iwai T, Nishida M, Kudo Y, Omotehara S, Kato K, Takakuwa E, Shimizu A, Kato F, Hosoda M, Takahashi M, Teshima T.A case of breast angiosarcoma clearly delineated by contrast-enhanced ultrasonography. J Clin Ultrasound. 2023 Jul-Aug;51(6):1048-1050. doi: 10.1002/jcu.23460. Epub 2023 Apr 6. PMID: 37025030
Kurosawa S, Imafuku K, Nakakubo S, Iwasaki S, Teshima T, Goto H, Ujiie H.Pseudotumor of the skin due to Mycobacterium genavense. Int J Infect Dis. 2023 Sep;134:88-90. doi: 10.1016/j.ijid.2023.05.004. Epub 2023 May 16. PMID: 37196757
Omotehara S, Nishida M, Kikuchi M, Kudo Y, Matsui A, Sato S, Murata SI, Gotoda H, Teshima T.Ultrasonographic diagnosis of cystitis glandularis with severe intestinal metaplasia. J Clin Ultrasound. 2023 Oct;51(8):1397-1400. doi: 10.1002/jcu.23513. Epub 2023 Jul 11. PMID: 37432965
Tada M, Kachi S, Onozawa M, Fujieda Y, Yoshida S, Oki Y, Kamada K, Nagai J, Okada S, Kikuchi R, Hisada R, Hasegawa Y, Ohigashi H, Goto H, Hashimoto D, Nakazato S, Matsuno Y, Teshima T, Atsumi T.Subcutaneous Panniculitis-like T-cell Lymphoma Lacking Subcutaneous Tumor Mimicking Adult-onset Still's Disease. Intern Med. 2023 Nov 1;62(21):3231-3235. doi: 10.2169/internalmedicine.1419-22. Epub 2023 Mar 15.PMID: 36927968
〈雑誌〉安本篤史 誌名：Modern Media Title：ヘパリン起因性血小板減少症の診断・治療を変える新規臨床検査 2023年12月
国際学会
〈招請講演〉T-cell exhaustion and GVHD/GVL（Invited Speaker） Takanori Teshima Joint ASTCT + EBMT Basic and Translational Scientific Meeting Sitges, Spain 2023年5月
〈一般口演〉Phase 2 study results of lisocabtagene maraleucel (liso-cel) in patients (pts) with R/R follicular lymphoma (FL) Frank Morschhauser,Saurabh Dahiya, M. Lia Palomba, Alejandro Martin Garcia-Sancho, Juan Luis Reguera, Ortega, John Kuruvilla, Ulrich Jager, Guillaume Cartron, Koji Izutsu, Martin Dreyling, Brad Kahl, Hervé Ghesquieres, Kirit Ardeshna, Hideki Goto, Anna Maria Barbui, Jeremy S. Abramson, Peter Borchmann, Isabelle Fleury, Stephan Mielke, Thalia Farazi, Omotayo Fasan, James Lymp, Min Vedal, Rina Nishii, Ariel Avilion, Jessica Papuga, Loretta J. Nastoupil International Conference on Malignant Lymphoma (ICML) Lugano, Swiss 2023年6月
〈ポスター〉EFFICACY AND SAFETY OF ZANDELISIB ADMINISTERED BY INTERMITTENT DOSING IN JAPANESE PATIENTS WITH RELAPSED/REFRACTORY INDOLENT B PRIMARY ANALYSIS OF THE PHASE 2 STUDY MIRAGE T. Kumode, W. Munakata, H. Goto, N. Fukuhara, T. Shimoyama, M. Takeuchi, T. Kawakita, K. Kubo, M. Sawa, T. Uchida, Y. Mishima, M. Ichii, M. Hanaya, A. Matsumoto, M. Kuriki, K. Izutsu, K. Ishizawa European Hematology Association 2023 Hybrid Congress Frankfurt, Germany 2023年6月
〈ポスター〉Assessment of the effectiveness, safety and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in routine clinical practice: 12-month results of the retrospective patients in the BICSTaR Japan study. Minami R, Watanabe D, Teruya K, Yokomaku Y, Endo T, Watanabe Y, Marongiu A, Tanikawa T, Heinzkill M, Shirasaka T, Oka S Asia-Pacific AIDS & Co-Infection Conference (APACC) 2023 Singapore 2023年6月
〈招請講演〉T-cell exhaustion and GVHD/GVL（Invited Speaker） Takanori Teshima Advances in Stem Cell Transplantation and Cell Therapy Freiburg, Germany 2023年6月
〈ポスター〉The risk of developing Pneumocystis jirovecii pneumonia persists even after completion of immunosuppressants in allogeneic hematopoietic stem cell transplantation recipients Takahide Ara, Shota Yokoyama, Yuta Hasegawa, Hiroyuki Ohigashi, Toshihiro Matsukawa, Atushi Yasumoto, Souichi Shiratori, Hideki Goto, Masahiro Onozawa, Masao Nakagawa, Kaoru Kahata, Tomoyuki Endo, Daigo Hashimoto, and Takanori Teshima EHA 2023 Frankfurt, Germany（WEB）2023年6月
〈ポスター〉CRP is a convenient predictive marker of the antipyretic effect of tocilizumab on CRS during CAR-T cell therapy Shota Yokoyama, Takahide Ara, Shinpei Harada, Yuto Mori, Yuta Hasegawa, Hiroyuki Ohigashi, Toshihiro Matsukawa, Atsushi Yasumoto, Souichi Shiratori, Masahiro Onozawa, Masao Nakagawa, Kaoru Kahata, Tomoyuki Endo, Daigo Hashimoto, Hideki Goto, and Takanori Teshima EHA 2023 Frankfurt, Germany（WEB）2023年6月
〈招請講演〉Haploidentical stem cell transplantation in Japan（Invited Speaker） Takanori Teshima 2023 TBMT Summer Forum & Ceremony of 10,000 Transplants Celebration Taipei,Taiwan 2023年7月
〈一般口演〉CNIs induce transitory-exhausted donor T cells and inhibit tolerance induction after allogeneic SCT Hajime Senjo, Daigo Hashimoto, Shimpei I Kubota, Yuki Tanaka, Shinpei Harada, Zixuan Zhang, Ryo Kikuchi, Yuta Hasegawa, Hiroyuki Ohigashi, Takahide Ara, Yoshinori Hasegawa, Masaaki Murakami and Takanori Teshima 13th Japan Society of Hematology International symposium 2023 Tsukuba 2023年7月
〈ポスター〉CRISPR Screen Identifies CD48 As A Key Molecule For NK Cell Immunity In Peripheral T-cell Lymphomas Masahiro Chiba, Joji Shimono, Takashi Ishio, Norio Takei, Kohei Kasahara, Reiki Ogasawara, Takahide Ara, Hideki Goto, Koh Izumiyama, Satoko Otsuguro, Liyanage P. Perera, Hiroo Hasegawa, Michiyuki Maeda, Satoshi Hashino, Katsumi Maenaka, Takanori Teshima, Thomas A. Waldmann, Yibin Yang and Masao Nakagawa The 13th JSH International Symposium 2023 in Tsukuba (Tsukuba) Tsukuba, Japan 2023年7月
〈招請講演〉New insights into the pathophysiology of GVHD（Invited Speaker） Takanori Teshima The International Congress of BMT 2023 Busan, Korea 2023年9月
〈シンポジウム〉The role of microbiota in immunity and hematopoiesis after HSCT Daigo Hashimoto 28th Annual Meeting of Asia-Pacific Blood and Marrow Transplantation Group Semarang, Indonesia 2023年10月
〈シンポジウム〉Real-world data of tisagenlecleucel in Japanese diffuse large B-cell lymphoma patients H Goto The 14th Asian Cellular Therapy Organization Fukuoka, Japan 2023年11月
〈招請講演〉CAR-T cell therapy in Japan（Invited Speaker） Takanori Teshima The 7th Vietnamese-French Open and Marrow Transplantation Congress Ho Chi Minh City,Vietnam 2023年11月
〈一般口演〉Phase 2 Study Primary Analysis of Lisocabtagene Maraleucel as Second-Line Therapy in Patients with High-risk Relapsed or Refractory Follicular Lymphoma F Morschhauser,S Dahiya, M.L Palomba, A.M Garcia-Sancho, J Luis, R Ortega, J Kuruvilla, U Jager, G Cartron, K Izutsu, M Dreyling, B Kahl, H Ghesquieres, K Ardeshna, H Goto, A.M Barbui, J S. Abramson, P Borchmann, I Fleury, S Mielke, A Skarbnik, S de Vos, M Kamdar, R Karmali, A Viardot, T Farazi, O Fasan, J Lymp, M Vedal, R Nishii, A Avilion, J Papuga, L J. Nastoupil 65th ASH Annual Meeting and Exposition, oral session San Diego, USA 2023年12月
〈ポスター〉Delayed Initiation of Calcineurin Inhibitor Is Critical for Tolerance Induction By Posttransplant Cyclophosphamide Hajime Senjo, Daigo Hashimoto, Satomi Okada, Shimpei I. Kubota, Ayumu Ito, Yumika Saito, Toru Miyajima, Wenyu Li, Zixuan Zhang, Shinpei Harada, Yuta Hasegawa, Hiroyuki Ohigashi, Takahide Ara, Yoshinori Hasegawa, Yoshihiro Inamoto, Masaaki Murakami, Takahiro Fukuda, and Takanori Teshima 65th American Society of Hematology Annual Meeting and Exposition 2023 San Diego 2023年12月
〈ポスター〉TP53 and CDKN2A Alterations Define a Poor Prognostic Subgroup in Patients with Nodal T-Follicular Helper Cell Lymphoma Yuta Ito, Joji Shimono, Keisuke Kawamoto, Kanako Hatanaka, Yasunori Kogure, Junji Koya, Koichi Murakami, Mariko Tabata, Yuki Saito, Mitsuhiro Yuasa, Kota Mizuno, Sara Horie, Yosuke Mizukami, Takanori Teshima, Yutaka Hatanaka, Hiroaki Miyoshi, Yoshihiro Matsuno, Koichi Ohshima, Keisuke Kataoka, Masao Nakagawa 65th American Society of Hematology Annual meeting San Diego, USA 2023年12月
〈一般口演〉Genome-wide CRISPR Screen Identifies MAD2L1BP, ANAPC15 and SLC39A7 as Intrinsic Regulators for Brentuximab Vedotin Sensitivity in Peripheral T-cell Lymphoma Cells Keito Suto, Masahiro Chiba, Takashi Ishio, Hideki Goto, Tomoyuki Endo, Michiyuki Maeda, Takanori Teshima, Masao Nakagawa 2023 ASH Annual Meeting San Diego 2023年12月
〈ポスター〉Genome-wide CRISPR Screen Identifies ZNF451 Regulating Sensitivity to Topoisomerase 2 Inhibitors in Peripheral T-cell Lymphoma Cells Keito Suto, Masahiro Chiba, Takashi Ishio, Hideki Goto, Tomoyuki Endo, Michiyuki Maeda, Takanori Teshima, Masao Nakagawa 2023 ASH Annual Meeting San Diego 2023年12月
〈ポスター〉Low-dose ATG has the same risk of CMV reactivation after allogeneic PBSCT as PTCY, but Letemovir is effective in preventing CMV reactivation Takahide Ara, Yuta Hasegawa, Hiroyuki Ohigashi, Toshihiro Matsukawa, Souichi Shiratori, Atsushi Yasumoto, Hideki Goto, Masahiro Onozawa, Masao Nakagawa, Kaoru Kahata, Tomoyuki Endo, Daigo Hashimoto, and Takanori Teshima ASH 2023 San Diego, USA（WEB）2023年12月
国内学会・研究会
〈セミナー〉安本篤史 VWDの周術期管理の問題点 von Willebrand病Online Seminar 札幌（WEB） 2023年1月
〈一般口演〉Koji Izutsu, Hideki Goto, Masahiro Kizaki, Masaki Yamaguchi, Noriko Fukuhara, Koji Kato, Toko Saito, Yasuhito Terui, Sumiko Okubo, Tomomi Soshin, Nabanita Mukherjee, Hideyuki Honda, Mohamed Badawi, Jeremy Ross, Kenichi Ishizawa Phase 2 Study of Ibrutinib Plus Venetoclax in Japanese Patients With Relapsed/Refractory Mantle Cell Lymphoma 20th Japanese Society of Medical Oncology Annual Meeting 福岡 2023年3月
〈一般口演〉市川貴也, 田村友和, 高畑むつみ, 石尾 崇, 井端 淳, 笠原郁美, 皆内康一郎, 山本 聡, 福原崇介 血液悪性腫瘍患者におけるSARS-CoV-2の持続感染に関する前向き研究 A prospective study on prolonged shedding of viable SARS-CoV-2 in immunocompromised patients with hematological malignancies 第70回日本ウイルス学会学術集会 仙台 2023年9月
〈一般口演〉Hideki Goto, Toshio Kitawaki, Koji Kato, Nobuharu Fujii, Yasushi Onishi, Noriko Fukuhara, Takuji Yamauchi, Kazunori Toratani, Masatoshi Shimo, Hiroki Kobayashi, Koichi Onodera, Shota Yoshida, Hajime Senjo, Masahiro Onozawa, Kenji Hirata, Isao Yokota, Takanori Teshima Impact of MTH and Dmax assessed by PET-CT on response to tisagenlecleucel treatment for lymphoma 第85回日本血液学会学術集会 東京 2023年10月
〈一般口演〉Hideki Goto, T. Kumode, W. Munakata, N. Fukuhara, T. Shimoyama, M. Takeuchi, T. Kawakita 7, N Kubo, M Sawa, T Uchida, Y Mishima, M Ichii, M. Hanaya, A. Matsumoto, K Izutsu, K. Ishizawa Phase 2 study of zandelisib in Japanese patients with relapsed/refractory indolent B-NHL 第85回日本血液学会学術集会 東京 2023年10月
〈一般口演〉Ayumi Fujimoto, Takeshi Maeda, Noriko Fukuhara, Noriko Iwaki, Nobuhiro Hiramoto, Hideki Goto, Takuya Miyazaki, Ikue Shiki, Kana Miyazaki, Motoko Yamaguchi, Fumihiro Ishida, Ritsuro Suzuki Improving prognosis of aggressive NK-cell leukemia: results of the nationwide survey in Japan 第85回日本血液学会学術集会 東京 2023年10月
〈一般口演〉Souichi Shiratori, Takanori Teshima, Yi-Bin Chen, Mohamad Mohty, Robert Zeiser, Ryou Nakaya, Guillermo Rossiter, Johan Jansson, Yngvar Floisand Vedolizumab for Prevention of Lower GI Acute Graft-versus-Host Disease in Japanese Patients 第85回日本血液学会学術集会 東京 2023年10月
〈一般口演〉李 明海, 安本篤史, 早坂光司, 豊嶋崇徳 Cytochalasin B amplifies the sensitivity of washed platelets to HIT antibodies 第85回日本血液学会学術集会 東京 2023年10月
